Guest guest Posted May 13, 2004 Report Share Posted May 13, 2004 Denver Health System is currently doing a PolyHeme study. EMS will randomly start either NS or PolyHeme in the field in selected patients. Here's the link to the page: http://www.denverhealth.org/TraumaCenter/Polyheme.aspx GG Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 13, 2004 Report Share Posted May 13, 2004 Are all the participating systems in the Denver area? GG In a message dated 5/13/2004 11:41:32 PM Central Daylight Time, jimmnn@... writes: >Denver Health System is currently doing a PolyHeme study. EMS will randomly >start either NS or PolyHeme in the field in selected patients. Here's the >link to the page: > It's actually a multi-center pre hospital trial Gene and we here in Denver are only 1 of about 20 systems participating. Jim< Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 13, 2004 Report Share Posted May 13, 2004 >Denver Health System is currently doing a PolyHeme study. EMS will randomly >start either NS or PolyHeme in the field in selected patients. Here's the >link to the page: > It's actually a multi-center pre hospital trial Gene and we here in Denver are only 1 of about 20 systems participating. Jim< Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 13, 2004 Report Share Posted May 13, 2004 >Denver Health System is currently doing a PolyHeme study. EMS will randomly >start either NS or PolyHeme in the field in selected patients. Here's the >link to the page: > It's actually a multi-center pre hospital trial Gene and we here in Denver are only 1 of about 20 systems participating. Jim< Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 14, 2004 Report Share Posted May 14, 2004 >Are all the participating systems in the Denver area? No just Denver Health and Hospitals which is Denver city and county. The surround 30 some that operate under the Denver Metro Protocols are not involved. Jim< Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 14, 2004 Report Share Posted May 14, 2004 >Are all the participating systems in the Denver area? No just Denver Health and Hospitals which is Denver city and county. The surround 30 some that operate under the Denver Metro Protocols are not involved. Jim< Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 14, 2004 Report Share Posted May 14, 2004 Here is a press release on the polyheme study in regards to an additional test site in south Texas. http://www.bizjournals.com/sanantonio/stories/2004/04/05/daily21.html ?jst=s_rs_hl Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 14, 2004 Report Share Posted May 14, 2004 Here is a press release on the polyheme study in regards to an additional test site in south Texas. http://www.bizjournals.com/sanantonio/stories/2004/04/05/daily21.html ?jst=s_rs_hl Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 14, 2004 Report Share Posted May 14, 2004 I think this is the current study. Jack http://www.clinicaltrials.gov/ct/show/NCT00076648?order=1 Safety and Efficacy of PolyHeme® in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting This study is currently recruiting patients. Sponsored by Northfield Laboratories Purpose This study is designed to assess the survival benefit of administering PolyHeme to severely injured trauma patients in hemorrhagic shock beginning in the prehospital setting, where blood is not available, and continuing throughout a 12-hour postinjury hospital setting. Condition Treatment or Intervention Phase Hemorrhagic Shock Drug: Poly SFH-P Injection Phase III MedlinePlus related topics: First Aid/Emergencies Study Type: Interventional Study Design: Treatment, Randomized, Open Label, Parallel Assignment, Safety/Efficacy Study Official Title: A Phase III, Randomized, Controlled, Open-Label, Multicenter, Parallel Group Study Using Provisions for Exception from Informed Consent Requirements Designed to Evaluate the Safety and Efficacy of Poly SFH-P Injection [Polymerized Human Hemoglobin (Pyridoxylated), PolyHeme®] When Used to Treat Patients in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Prehospital Setting Eligibility Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both Criteria Inclusion Criteria: Adult patients following trauma who have sustained blood loss and are in shock Exclusion Criteria: Patients who have sustained unsurvivable injuries Patients who have severe head injury Pregnant females Patients found in cardiac arrest Patients who object to participation (e.g., religious grounds, wearing exclusion bracelet). Location and Contact Information Colorado Denver Health Medical Center, Denver, Colorado, 80204, United States; Recruiting S Long, RRT Delaware Christiana Hospital, Newark, Delaware, 19718, United States; Recruiting Babenko, RN Ohio MetroHealth Medical Center, Cleveland, Ohio, 44109, United States; Recruiting Carolyn , RN Pennsylvania Lehigh Valley Hospital, town, Pennsylvania, 18103, United States; Recruiting Sabella, RN Tennessee University of Tennessee-Memphis, Memphis, Tennessee, 38163, United States; Recruiting Panzer, RN Texas Memorial-Hermann Hospital, Houston, Texas, 77030, United States; Recruiting Belanie Peavy-Abbs, RN More Information Study ID Numbers RTBSE-11-(N) Record last reviewed April 2004 NLM Identifier NCT00076648 ClinicalTrials.gov processed this record on 2004-05-14 Re: PolyHeme Study Are all the participating systems in the Denver area? GG In a message dated 5/13/2004 11:41:32 PM Central Daylight Time, jimmnn@... writes: >Denver Health System is currently doing a PolyHeme study. EMS will >randomly start either NS or PolyHeme in the field in selected patients. >Here's the link to the page: > It's actually a multi-center pre hospital trial Gene and we here in Denver are only 1 of about 20 systems participating. Jim< Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 14, 2004 Report Share Posted May 14, 2004 I think this is the current study. Jack http://www.clinicaltrials.gov/ct/show/NCT00076648?order=1 Safety and Efficacy of PolyHeme® in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting This study is currently recruiting patients. Sponsored by Northfield Laboratories Purpose This study is designed to assess the survival benefit of administering PolyHeme to severely injured trauma patients in hemorrhagic shock beginning in the prehospital setting, where blood is not available, and continuing throughout a 12-hour postinjury hospital setting. Condition Treatment or Intervention Phase Hemorrhagic Shock Drug: Poly SFH-P Injection Phase III MedlinePlus related topics: First Aid/Emergencies Study Type: Interventional Study Design: Treatment, Randomized, Open Label, Parallel Assignment, Safety/Efficacy Study Official Title: A Phase III, Randomized, Controlled, Open-Label, Multicenter, Parallel Group Study Using Provisions for Exception from Informed Consent Requirements Designed to Evaluate the Safety and Efficacy of Poly SFH-P Injection [Polymerized Human Hemoglobin (Pyridoxylated), PolyHeme®] When Used to Treat Patients in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Prehospital Setting Eligibility Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both Criteria Inclusion Criteria: Adult patients following trauma who have sustained blood loss and are in shock Exclusion Criteria: Patients who have sustained unsurvivable injuries Patients who have severe head injury Pregnant females Patients found in cardiac arrest Patients who object to participation (e.g., religious grounds, wearing exclusion bracelet). Location and Contact Information Colorado Denver Health Medical Center, Denver, Colorado, 80204, United States; Recruiting S Long, RRT Delaware Christiana Hospital, Newark, Delaware, 19718, United States; Recruiting Babenko, RN Ohio MetroHealth Medical Center, Cleveland, Ohio, 44109, United States; Recruiting Carolyn , RN Pennsylvania Lehigh Valley Hospital, town, Pennsylvania, 18103, United States; Recruiting Sabella, RN Tennessee University of Tennessee-Memphis, Memphis, Tennessee, 38163, United States; Recruiting Panzer, RN Texas Memorial-Hermann Hospital, Houston, Texas, 77030, United States; Recruiting Belanie Peavy-Abbs, RN More Information Study ID Numbers RTBSE-11-(N) Record last reviewed April 2004 NLM Identifier NCT00076648 ClinicalTrials.gov processed this record on 2004-05-14 Re: PolyHeme Study Are all the participating systems in the Denver area? GG In a message dated 5/13/2004 11:41:32 PM Central Daylight Time, jimmnn@... writes: >Denver Health System is currently doing a PolyHeme study. EMS will >randomly start either NS or PolyHeme in the field in selected patients. >Here's the link to the page: > It's actually a multi-center pre hospital trial Gene and we here in Denver are only 1 of about 20 systems participating. Jim< Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 14, 2004 Report Share Posted May 14, 2004 I think this is the current study. Jack http://www.clinicaltrials.gov/ct/show/NCT00076648?order=1 Safety and Efficacy of PolyHeme® in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting This study is currently recruiting patients. Sponsored by Northfield Laboratories Purpose This study is designed to assess the survival benefit of administering PolyHeme to severely injured trauma patients in hemorrhagic shock beginning in the prehospital setting, where blood is not available, and continuing throughout a 12-hour postinjury hospital setting. Condition Treatment or Intervention Phase Hemorrhagic Shock Drug: Poly SFH-P Injection Phase III MedlinePlus related topics: First Aid/Emergencies Study Type: Interventional Study Design: Treatment, Randomized, Open Label, Parallel Assignment, Safety/Efficacy Study Official Title: A Phase III, Randomized, Controlled, Open-Label, Multicenter, Parallel Group Study Using Provisions for Exception from Informed Consent Requirements Designed to Evaluate the Safety and Efficacy of Poly SFH-P Injection [Polymerized Human Hemoglobin (Pyridoxylated), PolyHeme®] When Used to Treat Patients in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Prehospital Setting Eligibility Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both Criteria Inclusion Criteria: Adult patients following trauma who have sustained blood loss and are in shock Exclusion Criteria: Patients who have sustained unsurvivable injuries Patients who have severe head injury Pregnant females Patients found in cardiac arrest Patients who object to participation (e.g., religious grounds, wearing exclusion bracelet). Location and Contact Information Colorado Denver Health Medical Center, Denver, Colorado, 80204, United States; Recruiting S Long, RRT Delaware Christiana Hospital, Newark, Delaware, 19718, United States; Recruiting Babenko, RN Ohio MetroHealth Medical Center, Cleveland, Ohio, 44109, United States; Recruiting Carolyn , RN Pennsylvania Lehigh Valley Hospital, town, Pennsylvania, 18103, United States; Recruiting Sabella, RN Tennessee University of Tennessee-Memphis, Memphis, Tennessee, 38163, United States; Recruiting Panzer, RN Texas Memorial-Hermann Hospital, Houston, Texas, 77030, United States; Recruiting Belanie Peavy-Abbs, RN More Information Study ID Numbers RTBSE-11-(N) Record last reviewed April 2004 NLM Identifier NCT00076648 ClinicalTrials.gov processed this record on 2004-05-14 Re: PolyHeme Study Are all the participating systems in the Denver area? GG In a message dated 5/13/2004 11:41:32 PM Central Daylight Time, jimmnn@... writes: >Denver Health System is currently doing a PolyHeme study. EMS will >randomly start either NS or PolyHeme in the field in selected patients. >Here's the link to the page: > It's actually a multi-center pre hospital trial Gene and we here in Denver are only 1 of about 20 systems participating. Jim< Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.